Literature DB >> 9449228

Immunology of xenotransplantation.

S Saadi1, J L Platt.   

Abstract

The transplantation of tissues and organs between individuals of different species, that is, xenotransplantation, engenders a variety of immune responses. Xenogeneic immune responses mediated by naturally-occurring antibodies and complement lead to hyperacute and acute vascular rejection of vascularized organ grafts and may also cause vascular rejection of cell and tissue grafts. Under some circumstances, however, a vascularized organ graft may evade humoral rejection despite the presence of anti-donor antibodies in the circulation of the recipient; this condition is called accommodation. Xenogeneic immune responses mediated by T lymphocytes and natural killer cells may cause acute cellular rejection. The extent to which cellular rejection of xenografts resembles cellular rejection of allografts remains to be determined. New insights into the molecular mechanisms underlying the immune responses to xenotransplantation has shed light on the pathogenesis of immunological disease and has allowed the development of specific immunomodulatory strategies that may facilitate clinical application of xenotransplantation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449228     DOI: 10.1016/s0024-3205(97)00964-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

Review 1.  Xenotransplantation--2000.

Authors:  M J Goddard; J E Foweraker; J Wallwork
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

2.  Human umbilical cord blood cells alter blood and spleen cell populations after stroke.

Authors:  J E Golden; M Shahaduzzaman; A Wabnitz; S Green; T A Womble; P R Sanberg; K R Pennypacker; A E Willing
Journal:  Transl Stroke Res       Date:  2012-09-04       Impact factor: 6.829

3.  Fate of endothelialized modular constructs implanted in an omental pouch in nude rats.

Authors:  Rohini Gupta; Nico Van Rooijen; Michael V Sefton
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

4.  Heart xenograft survival with chimeric pig donors and modest immune suppression.

Authors:  William E Beschorner; Debra L Sudan; Stanley J Radio; Tianyu Yang; Kenneth L Franco; Arthur C Hill; C Carson Shearon; Scott C Thompson; Robert S Dixon; Noel D Johnson; Charles A Kuszynski; Ronald J Rubocki; Kelly F Lechtenberg; Aurelio Matamoros; Timothy C Goertzen; Ira J Fox; Alan N Langnas
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

5.  An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA.

Authors:  K A Thomas; N M Valenzuela; D Gjertson; A Mulder; M C Fishbein; G C Parry; S Panicker; E F Reed
Journal:  Am J Transplant       Date:  2015-04-22       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.